Increased Expression of miR-202-3p in Patients with Relapsing-Remitting Multiple Sclerosis

Increased Expression of miR-202-3p in Patients with Relapsing-Remitting Multiple Sclerosis

Background and objectives: One of the latest studies in the genetics field is the evaluation of role of micro-RNAs as a biomarker for diagnosis of multiple sclerosis (MS), which is a demyelinating disease of the central nervous system (CNS) and emerges in the form of numerous small and large plaques...

Full description

Bibliographic Details
Main Authors:	Majid Amini Khorasgani, Parisa Mohammady Nejad, Mohammad Mehdi Moghani Bashi
Format:	Article
Language:	English
Published:	Golestan University of Medical Sciences 2018-12-01
Series:	Jorjani Biomedicine Journal
Subjects:	Multiple Sclerosis RRMS miR-202-3p ADA Gene
Online Access:	http://goums.ac.ir/jorjanijournal/browse.php?a_code=A-10-453-1&slc_lang=en&sid=1

Similar Items

Evaluation of mir-377-3p Expression in Patients with Multiple Sclerosis
by: Majid Amini Khorasgani, et al.
Published: (2019-06-01)

The STING-IFN-β-Dependent Axis Is Markedly Low in Patients with Relapsing-Remitting Multiple Sclerosis
by: Lars Masanneck, et al.
Published: (2020-12-01)

Identification de nouveaux miARNs ovariens et analyse fonctionnelle de mir202 chez le médaka (Oryzias latipes)
by: Bouchareb, Mohamed Amine
Published: (2016)

miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway
by: Wei Sun, et al.
Published: (2018-12-01)

Comparing the Safety and Efficacy of Ziferon and Betaferon in Patients With Remitting-Relapsing Multiple Sclerosis
by: Mohammad Reza Gheini, et al.
Published: (2019-11-01)

Correlation of serum miR-202 expression with tumor marker levels and oncogene expression in patients with liver cancer
by: Zhen Lu, et al.
Published: (2018-07-01)

Reduced serum miR‐202 may promote the progression of Alzheimer's disease patients via targeting amyloid precursor protein
by: Li‐Hua Dong, et al.
Published: (2021-08-01)

Upregulated lncRNA Gm2044 inhibits male germ cell development by acting as miR-202 host gene
by: Meng Liang, et al.
Published: (2019-03-01)

Automated quantification of deep grey matter structures and white matter lesions using magnetic resonance imaging in relapsing remission multiple sclerosis
by: Mina Rizkallah, et al.
Published: (2021-09-01)

Diagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea
by: Jungho Kim, et al.
Published: (2020-07-01)

A case report revealing acute onset psychosis and cognitive impairment as primary manifestation in relapsing‐remitting multiple sclerosis
by: Anirban Nandy, et al.
Published: (2020-05-01)

Ocrelizumab as a breakthrogh in multiple sclerosis treatment
by: Marcin Zaniuk, et al.
Published: (2021-05-01)

lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis
by: Zhang J, et al.
Published: (2021-04-01)

Studying the Expression of SNX2 (Sorting nexin-2) in Patients with RRMS Compared with Health Control
by: Fariba Bani Talebi Dehkordi, et al.
Published: (2017-06-01)

Interleukin 6 but not Interleukin 8 Might be an Indicator of Multiple Sclerosis Progression from Relapse Remitting to Secondary Progressive Status
by: Mina Eslami, et al.
Published: (2020-02-01)

Increased Circulating miR-10a Levels Associated with Multiple Sclerosis
by: Niloofar Boroumand, et al.
Published: (2018-12-01)

Cognitive Dysfunction in Multiple Sclerosis: Educational Level as a Protective Factor
by: Mar Estrada-López, et al.
Published: (2021-07-01)

Realidad social peruana - TR202 201801
by: Universidad Peruana de Ciencias Aplicadas (UPC), et al.
Published: (2018)

MicroRNA-202-3p Targets Brain-Derived Neurotrophic Factor and Is Involved in Depression-Like Behaviors
by: Xin C, et al.
Published: (2020-04-01)

lncRNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promotes Proliferation and Invasion of Non-Small Cell Lung Cancer Cells via Down-Regulating miR-202 Expression
by: Guo Tiansheng, et al.
Published: (2020-10-01)

The Effect of Beta Interferon on the Expression of miR-145 in Patients with Multiple Sclerosis
by: Naeim Ehtesham, et al.
Published: (2016-11-01)

MRI Analysis of White Matter Myelin Water Content in Multiple Sclerosis: A Novel Approach Applied to Finding Correlates of Cortical Thinning
by: Michael Dayan, et al.
Published: (2017-05-01)

Upregulation of CD4+ T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients
by: Aref Hosseini, et al.
Published: (2016-09-01)

Down-Regulation Smurf2 (Smad ubiquitin Regulatory Factor 2) Gene in Patients With RRMS and Association With High Disability
by: F Behdarvand Dehkordi, et al.
Published: (2018-11-01)

Population-based Resequencing of LIPG and ZNF202 Genes in Subjects with Extreme HDL Levels
by: Hamid eRazzaghi, et al.
Published: (2012-06-01)

Cerebellum and brain stem volume loss in relapsing remission multiple sclerosis by MRI volumetry: relation to neurological disability score and number of relapses
by: Magdy Elzayady, et al.
Published: (2021-01-01)

Genetic Association of MiR-146a with Multiple Sclerosis Susceptibility in the Chinese Population
by: You Li, et al.
Published: (2015-01-01)

Linear Modeling of Multiple Sclerosis and Its Subgroubs
by: Yeliz Karaca, et al.
Published: (2015-03-01)

MiR-202-5p Inhibits RIG-I-Dependent Innate Immune Responses to RGNNV Infection by Targeting TRIM25 to Mediate RIG-I Ubiquitination
by: Wei Liu, et al.
Published: (2020-02-01)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
by: Oliver Findling, et al.
Published: (2018-08-01)

Proso millet national variety TNAU 202
by: A. Nirmalakumari*, A. Subramanian, S. Manoharan, T. Raguchander, P. Veerabadhiran, K. Thiyagarajan, M. Paramathma and C. Priyadharshini
Published: (2021-03-01)

From Roscovitine to CYC202 to Seliciclib – from bench to bedside: discovery and development
by: Nikolai Zhelev, et al.
Published: (2013-12-01)

Multiple Sclerosis Relapsing Remitting Progressive Type
by: Nora Fitri, et al.
Published: (2020-12-01)

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
by: Burcu Altunrende, et al.
Published: (2017-12-01)

miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review
by: Karina Maciak, et al.
Published: (2021-04-01)

Genetic Association and Altered Gene Expression of Mir-155 in Multiple Sclerosis Patients
by: Rosanna Asselta, et al.
Published: (2011-12-01)

Advances in the treatment of relapsing - Remitting multiple sclerosis
by: Radu Tanasescu, et al.
Published: (2014-04-01)

The pattern of thyroiditis in multiple sclerosis: a cross-sectional study in a tertiary care hospital in Egypt
by: Nearmeen M. Rashad, et al.
Published: (2020-10-01)

Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS
by: Ilona B. Bruinsma, et al.
Published: (2017-12-01)

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01)